Surgical Treatment of Cardiac Myxoma: A 20 Years of Experiences.
- Author:
Hong Joo SEO
1
;
Chan Young NA
;
Sam Se OH
;
Jae Hyun KIM
;
Kil Soo YIE
;
Man Jong BAEK
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Chosun University College of Medicine, Korea.
- Publication Type:Original Article
- Keywords:
Myxoma;
Heart neoplasms
- MeSH:
Adult;
Angiography;
Chest Pain;
Death, Sudden, Cardiac;
Diagnosis;
Dyspnea;
Echocardiography;
Female;
Follow-Up Studies;
Heart Atria;
Heart Neoplasms;
Hemodynamics;
Humans;
Male;
Myxoma*;
Recurrence;
Syncope
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2007;40(4):288-291
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Myxoma makes up close to 50% of adult primary cardiac tumors, and this mainly occurs in the left atrium, and rarely in the right atrium or ventricle. The patients clinically present with symptoms of hemodynamic obstruction, embolization or constitutional changes. Diagnosis is currently established most appropriately with 2-D echocardiography. Surgical resection of myxoma is a safe and effective treatment. MATERIAL AND METHOD: We reviewed our clinical experience in the diagnosis and management of 57 cases of cardiac myxoma that were seen over a 20-year period from July 1984 to July 2004. RESULT: The mean age of the patients was 53.5+/-14.0 years (range: 12 to 76 years). There were 38 (67%) females and 19 (33%) males. The preoperative symptoms included dyspnea on exertion in 27 patients, palpitation in 4, chest pain in 9 and syncopal episode in 4. The diagnosis was made by echocardiography alone in 51, and by combination of echocardiography, CT and angiography in 6. The tumor attachment sites were the interatrial septum in 50, the mital valve annulus in 3 and the left atrial wall in cases. The tumor was excised successfully via biatriotomy in 33 (58%), left atriotomy in 15 (26%), the septal approach via right atriotomy in 3, Inverted T incision in 3 and the extended septal approach in 3. The follow-up time ranged from 1 to 229 months (mean follow-up: 84.0+/-71.3 months). There were no early and late deaths and no recurrence during the follow-up period except for follow-up loss in 5 patients. CONCLUSION: It's concluded that excision of cardiac myxoma is curative and the long-term survival is excellent. Immediate surgical treatment was indicated because of the high risk of embolization or of sudden cardiac death. Radical tumor excision may prevent recurrences.
